Chromosome 13 Abnormality Recruiting Phase 2 Trials for Cyclosporine (DB00091)

IndicationStatusPhase
DBCOND0116304 (Chromosome 13 Abnormality)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00719888Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic DiseaseTreatment